Pembrolizumab for Colorectal Cancer User Reviews
Brand names: Keytruda
Pembrolizumab has an average rating of 6.2 out of 10 from a total of 4 reviews for the treatment of Colorectal Cancer. 50% of reviewers reported a positive experience, while 25% reported a negative experience.
- ned
- Taken for 1 to 6 months
- January 21, 2022
Keytruda (pembrolizumab) "My doctor tried this after everything else has failed. It didn't work, in fact it did nothing good what so ever. My CEA went from 479 to over 2000, the highest it has been since I got cancer in 2016. It might work for some but I haven't heard of it benefitting anyone. Good luck to those who use it."
- Anonymous
- Taken for 6 months to 1 year
- October 30, 2017
"Worked well on reducing the size of tumours in first 6 cycles. But then I started getting lots of stomach problems , and vomiting. I have lost 10kgs in weight. I have been hoping that since stopping the trial in August 2017 , the effects would go away, to date Oct 30 2017 , not so. However initially it did seem a miracle drug that the tumours respnded so well. However I have more tumours progressing now, so it clearly stopped responding."
Frequently asked questions
- Pembrolizumab vs. nivolumab: How do they compare?
- How are Inlyta and Keytruda used in kidney cancer?
- What type of cancer is pembrolizumab used for?
- How does pembrolizumab affect the immune system?
- Charlie
- Taken for 2 to 5 years
- January 24, 2023
Keytruda (pembrolizumab) "Keytruda wiped out most of my colon cancer and I’ve been in full remission for well over 3 years."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
Learn more about Colorectal Cancer
Care guides
Symptoms and treatments
Medicine.com guides (external)
More about pembrolizumab
- Check interactions
- Compare alternatives
- Reviews (227)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
"I had colon cancer & metastatic at stage 3B. 1cycles=8x od Xelox was given to me but not longer working. Start from cea 27 (before did operation on my colon, there are any metastatic on 4 of my lymph node) & after finishing the xelox’s cycles the cea level going up to 510. After this treatment failed, I decide to changed my oncologist as she won't stop using xelox & I wanted to try to used keytruda pembrolizumab for 100ml/every 3 weeks. My weight 53kg. Before I started the first keytruda, I don't know why the level cea has been going down to 358. So I started from a cea 358. She has been given me 3x keytruda. She given me every /3weeks.My doctor advice me to take this immunotherapy keytruda treatment for 8x-16x (Dependent on future situation). And now after the 3rd treatment, the result of my level cea shown going down to 20.58. Every treatment going down until 50% of level cea. I hope before I finish this treatment for 8x (now I am having 4th treatment) it will go down to NORMAL range"